Squarepoint Ops LLC - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 123 filers reported holding INTERSECT ENT INC in Q1 2020. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q2 2021$257,000
-35.8%
15,024
-21.5%
0.00%
-50.0%
Q1 2021$400,000
-34.6%
19,136
-49.0%
0.00%
-75.0%
Q3 2020$612,000
-48.9%
37,550
-21.9%
0.01%
+14.3%
Q4 2019$1,197,000
+51.9%
48,061
+38.7%
0.01%
-12.5%
Q2 2019$788,000
-30.0%
34,639
-1.0%
0.01%
-33.3%
Q1 2019$1,125,000
-14.3%
34,987
-24.9%
0.01%
-20.0%
Q4 2018$1,313,000
-0.8%
46,588
+1.2%
0.02%
-6.2%
Q3 2018$1,324,000
-10.5%
46,041
+16.6%
0.02%
-20.0%
Q2 2018$1,479,000
+33.8%
39,500
+40.5%
0.02%
+11.1%
Q1 2018$1,105,000
+26.9%
28,113
+4.6%
0.02%
+20.0%
Q4 2017$871,000
+58.1%
26,880
+52.1%
0.02%
+36.4%
Q3 2017$551,000
+126.7%
17,676
+103.2%
0.01%
+120.0%
Q2 2017$243,000
-37.9%
8,700
-73.1%
0.01%
-68.8%
Q4 2016$391,000
+7.1%
32,313
+99.5%
0.02%
-60.0%
Q4 2015$365,00016,2000.04%
Other shareholders
INTERSECT ENT INC shareholders Q1 2020
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 186,561$5,364,0004.51%
First Light Asset Management, LLC 517,121$14,867,0002.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,147,950$61,754,0002.21%
HealthCor Management, L.P. 1,950,000$56,063,0001.86%
PURA VIDA INVESTMENTS, LLC 200,000$5,750,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 112,000$2,469,0001.17%
Broadfin Capital, LLC 234,200$6,733,0000.99%
Lombard Odier Asset Management (USA) Corp 240,000$6,900,0000.51%
PURA VIDA INVESTMENTS, LLC 83,527$2,401,0000.50%
Rock Springs Capital Management LP 460,000$13,225,0000.48%
View complete list of INTERSECT ENT INC shareholders